HRMY - CIK 0001802665
Harmony Biosciences Holdings, Inc. (HRMY) reported net income of $158.69M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $158.69M | +9.1% |
| FY 2024 | $145.49M | +12.9% |
| FY 2023 | $128.85M | -29.0% |
| FY 2022 | $181.47M | +424.5% |
| FY 2021 | $34.60M | +193.6% |
| FY 2020 | -$36.94M | +75.7% |
| FY 2019 | -$151.98M | - |
Harmony Biosciences Holdings, Inc. (HRMY) reported net income of $158.69M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Harmony Biosciences Holdings, Inc.'s net income grew from -$151.98M to $158.69M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.